Background Contrast-induced acute kidney injury (CI-AKI) is a major adverse effect caused
by intravascular administration of iodinated contrast medium. Whether there is a difference …

Background: The optimal revascularization strategy for patients with left main coronary artery
disease (LMCAD) and chronic kidney disease (CKD) remains unclear. Objectives: This …

Iodixanol is an iso-osmolar non-ionic dimeric hydrophilic contrast agent with a higher
viscosity than the monomeric agents. It is the only Food and Drug Administration (FDA) …

Background We studied the incidence and risk factors of acute kidney injury (AKI) following
coronary angiography (CA) and examined short-and long-term outcomes of patients who …

Introduction: The evidence about the optimal revascularization strategy in patients with left
main coronary artery (LMCA) disease and impaired renal function is limited. Thus, we aimed …

We examined short‐and long‐term outcomes of coronary artery bypass grafting (CABG) in
patients with ischemic heart disease and the effect of renal function on these outcomes. We …

Objective: to demonstrate scientific evidence on incidence and factors associated with
contrast-induced nephropathy in patients undergoing percutaneous coronary intervention …

Hepatorenal syndrome (HRS) is an acute complication of advanced liver disease, which
manifests with a rapidly progressive decline in kidney function. Though pharmacological …

Contrast-induced nephropathy is the leading cause of acute kidney injury in hospital
settings. Practitioners must have a comprehensive understanding of preventive …

Objetivo: demonstrar evidências científicas sobre incidência e fatores associados à
nefropatia induzida por contraste em pacientes submetidos à intervenção coronária …